AT-RISK PROVIDERS
Reduce unnecessary utilization and support better outcomes under value-based contracts with MRIoA’s clinical review expertise.
Learn More
We Help You Succeed in Value-Based Care
As your clinical partner and an extension of your team, at-risk provider groups gain access to expert review, peer consultation, and resources needed to confidently manage cost and quality across your patient population.
At-risk provider groups face the fundamental challenge of bearing financial responsibility for the total cost of care. Yet they often lack the in-house clinical review infrastructure to identify overutilization, address high-cost drug spend and medical costs, and ensure appropriate care for complex cases.
MRIoA provides clinical health and pharmacy reviews, peer-to-peer consultation, and multi-specialty expertise in all 50 states to help at-risk providers ensure patients receive appropriate, evidence-based care, while lowering medical costs, reducing unnecessary procedures, and improving quality outcomes without adding permanent overhead to their organizations.
Built for the Demands of Value-Based Care
- Health and pharmacy reviews that are grounded in the latest clinical guidelines, align with the organization’s policies, and ensure that patients receive appropriate, cost-effective care
- A robust panel covering 150+ specialties nationwide ensures patient cases always get a knowledgeable, specialty-matched reviewer
- Peer-to-peer consultations with board-certified specialists to resolve complex cases and support informed care decisions
- URAC accreditation and proactive regulatory monitoring ensure every review meets compliance standards, giving at-risk providers confidence that every decision is defensible
- Expert review capacity that supports your population size and case complexity without adding permanent staff
- Expertise in high-cost drug reviews to manage drug spend without compromising patient care
Review Services Configured for At-Risk Provider Groups
MRIoA’s clinical review services are configured to support the quality, utilization, and cost management goals of at-risk provider organizations.
How At-Risk Providers Partner with MRIoA
Our consultative model gives at-risk providers the independent, expert review that supports specialist access and utilization management reviews needed to manage costs.
Health Reviews
Our team of clinicians, nurses, pharmacy technicians, pharmacists, and physicians conduct objective reviews of medical necessity, appropriateness, and level of care—providing the independent assessment needed to support evidence-based utilization decisions and identify where care can be improved.
Pharmacy Reviews
We support your team so you can focus on patient care and value-based performance. Our team conducts peer-to-peer consultations when clinical clarification is needed. We support pharmacy and therapeutics committee decisions and help ensure medication use aligns with evidence-based guidelines, cost management goals, and quality outcomes.
Specialty Reviews
We provide expert review in high-cost, high-variation specialties including behavioral health, musculoskeletal, radiology, genetic testing, pain management, and sleep medicine—areas where independent clinical perspective most directly impacts quality and cost outcomes.
Peer-to-Peer Consultation
Our panel of 700+ specialists across 150+ specialties is available for peer-to-peer consultations that help your clinicians resolve complex cases, align on treatment appropriateness, and support informed care decisions without delay.
Where Clinical Quality and Cost Performance Converge
Independent clinical expertise helps at-risk providers reduce unnecessary costs and succeed under value-based contracts.
Perspectives for At-Risk Providers
From Policy to Practice: What Today’s Regulatory Shifts Mean for Clinical and Pharmacy Operations
Help Your Patients Get the Right Care—and Protect Your Performance Under Risk
Contact us today for help with your risk contracts.


